Literature DB >> 1736883

Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor.

B S Murthy1, R Sirdeshmukh.   

Abstract

We have studied the inhibition of bovine pancreatic RNAase (RNAase A) and bovine seminal RNAase in its native dimeric form (RNAase BS-1) and in monomeric carboxymethylated form (MCM RNAase BS-1) by human placental RNAase inhibitor (RNAase inhibitor) in order to understand the effect of enzyme structure on its response to the inhibitor. Study of the inhibition as a function of inhibitor concentration revealed that RNAase A and MCM RNAase BS-1 were inhibited fully and the inhibitor-sensitivities of the two were comparable. But under identical inhibitor concentrations RNAase BS-1 was found to be virtually insensitive to the inhibitor; at higher (3-10-fold) inhibitor concentrations marginal inhibition of the native enzyme could be observed. When RNAase BS-1 was pretreated with 5 mM-dithiothreitol (DTT) and assayed, it exhibited greater inhibitor-sensitivity, presumably as a result of its partial monomerization on exposure to DTT. This DTT-mediated change in the response of RNAase BS-1 to the inhibitor did not, however, seem to occur either in the assay conditions (which included DTT) or even when the enzyme was pretreated with DTT in the presence of the substrate, suggesting an effect of the substrate on the enzyme behaviour towards the inhibitor. Independently, gel-filtration runs revealed that, although DTT treatment caused monomerization of RNase BS-1, this change did not take place when DTT treatment was carried out in the presence of the substrate. From our observations, we infer that differential inhibitor-sensitivity of the dimeric and monomeric forms of RNAase BS-1, the relative contents of the two forms and the influence of the substrate on them may be important determinants of the net enzyme activity in the presence of the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736883      PMCID: PMC1130689          DOI: 10.1042/bj2810343

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Dissociation of bovine seminal ribonuclease into catalytically active monomers by selective reduction and alkylation of the intersubunit disulfide bridges.

Authors:  G D'Alessio; M C Malorni; A Parente
Journal:  Biochemistry       Date:  1975-03-25       Impact factor: 3.162

2.  On the aggregation of bovine pancreatic ribonuclease.

Authors:  A M CRESTFIELD; W H STEIN; S MOORE
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

3.  Theoretical treatment of tight-binding inhibition of an enzyme. Ribonuclease inhibitor as special case.

Authors:  J M Fominaya; J M García-Segura; M Ferreras; J G Gavilanes
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

4.  Purification and characterisation of ribonuclease activities that interact with the cytoplasmic inhibitor protein of rat tissues.

Authors:  N A Brockdorff; J T Knowler
Journal:  Eur J Biochem       Date:  1987-02-16

5.  Preparation and properties of two active forms of ribonuclease dimer.

Authors:  R G Fruchter; A M Crestfield
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

6.  Synthesis of seminal ribonuclease in isolated lobules of bull seminal vesicles.

Authors:  N Quarto; G F Tajana; G D'Alessio
Journal:  J Reprod Fertil       Date:  1987-05

7.  Multiple forms of ribonuclease II in mouse liver: relative sizes, subcellular distributions, and pH-activity profiles.

Authors:  S R Kimball; W L Meyer
Journal:  Biochem Cell Biol       Date:  1987-01       Impact factor: 3.626

8.  Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.

Authors:  R Shapiro; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

9.  Complete amino-acid sequence of bovine seminal ribonuclease, a dimeric protein from seminal plasma.

Authors:  H Suzuki; A Parente; B Farina; L Greco; R La Montagna; E Leone
Journal:  Biol Chem Hoppe Seyler       Date:  1987-10

10.  Interaction of human placental ribonuclease with placental ribonuclease inhibitor.

Authors:  R Shapiro; B L Vallee
Journal:  Biochemistry       Date:  1991-02-26       Impact factor: 3.162

View more
  15 in total

1.  Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Ronald T Raines
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

2.  RNase inhibition of human immunodeficiency virus infection of H9 cells.

Authors:  R J Youle; Y N Wu; S M Mikulski; K Shogen; R S Hamilton; D Newton; G D'Alessio; M Gravell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

Review 3.  Designing immunotoxins for cancer therapy.

Authors:  Christopher A Pennell; Heidi A Erickson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  1H and 15N sequential assignment and solution secondary structure of 15N labelled human pancreatic ribonuclease.

Authors:  A el-Joubary; M Bruix; J Santoro; V Cafaro; R Scognamiglio; A Di Donato; G D'Alessio; K E Kövér; G Batta; L Szilágyi; M Rico
Journal:  J Biomol NMR       Date:  1999-11       Impact factor: 2.835

5.  Antitumor activity of ribonuclease multimers created by site-specific covalent tethering.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Christine I Schilling; Ronald T Raines
Journal:  Bioconjug Chem       Date:  2010-09-15       Impact factor: 4.774

6.  Ribonucleases endowed with specific toxicity for spermatogenic layers.

Authors:  Josef Matoušek; Jin-Soo Kim; Josef Souček; Jan Rìha; Marc Ribó; Peter A Leland; Ronald T Raines
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1997-12       Impact factor: 2.231

7.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 8.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 9.  Oligomerization of bovine ribonuclease A: structural and functional features of its multimers.

Authors:  Massimo Libonati; Giovanni Gotte
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

10.  Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform.

Authors:  Thomas Schirrmann; André Frenzel; Lars Linden; Beatrix Stelte-Ludwig; Jörg Willuda; Axel Harrenga; Stefan Dübel; Beate Müller-Tiemann; Mark Trautwein
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.